Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients

2007, The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007), Ocul Surf, 5, 75, 10.1016/S1542-0124(12)70081-2 2007, The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007), Ocul Surf, 5, 93, 10.1016/S1542-0124(12)70082-4 Galor, 2012, Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database, Am J Ophthalmol, 154, 340, 10.1016/j.ajo.2012.02.009 Schaumberg, 2009, Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies, Arch Ophthalmol, 127, 763, 10.1001/archophthalmol.2009.103 Schaumberg, 2003, Prevalence of dry eye syndrome among US women, Am J Ophthalmol, 136, 318, 10.1016/S0002-9394(03)00218-6 Friedman, 2010, Impact of dry eye disease and treatment on quality of life, Curr Opin Ophthalmol, 21, 310, 10.1097/ICU.0b013e32833a8c15 Pouyeh, 2012, Impact of ocular surface symptoms on quality of life in a United States veterans affairs population, Am J Ophthalmol, 153, 1061, 10.1016/j.ajo.2011.11.030 Schiffman, 2003, Utility assessment among patients with dry eye disease, Ophthalmology, 110, 1412, 10.1016/S0161-6420(03)00462-7 Sambursky, 2014, Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease, Cornea, 33, 812, 10.1097/ICO.0000000000000175 Stern, 2013, Dry eye as a mucosal autoimmune disease, Int Rev Immunol, 32, 19, 10.3109/08830185.2012.748052 Niederkorn, 2006, Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis, J Immunol, 176, 3950, 10.4049/jimmunol.176.7.3950 Prabhasawat, 1998, Frequent association of delayed tear clearance in ocular irritation, Br J Ophthalmol, 82, 666, 10.1136/bjo.82.6.666 McCabe, 2009, Advancements in anti-inflammatory therapy for dry eye syndrome, Optometry, 80, 555, 10.1016/j.optm.2009.02.010 Sall, 2000, Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group, Ophthalmology, 107, 631, 10.1016/S0161-6420(99)00176-1 Sambursky, 2013, Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye, JAMA Ophthalmol, 131, 24, 10.1001/jamaophthalmol.2013.561 Lanza, 2016, The matrix metalloproteinase 9 point-of-care test in dry eye, Ocul Surf, 14, 189, 10.1016/j.jtos.2015.10.004 Chotikavanich, 2009, Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome, Invest Ophthalmol Vis Sci, 50, 3203, 10.1167/iovs.08-2476 Aragona, 2015, Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease, Ophthalmology, 122, 62, 10.1016/j.ophtha.2014.07.048 Pflugfelder, 2003, Anti-inflammatory therapy of dry eye, Ocul Surf, 1, 31, 10.1016/S1542-0124(12)70005-8 Zoukhri, 2006, Effect of inflammation on lacrimal gland function, Exp Eye Res, 82, 885, 10.1016/j.exer.2005.10.018 Tseng, 2013, IL-1beta promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-kappaB- and AP-1-dependent pathways, PLoS One, 8, e57955, 10.1371/journal.pone.0057955 Hessen, 2014, Dry eye: an inflammatory ocular disease, J Ophthalmic Vis Res, 9, 240 Luo, 2004, Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface, Invest Ophthalmol Vis Sci, 45, 4293, 10.1167/iovs.03-1145 Klein, 2011, Physiology and pathophysiology of matrix metalloproteases, Amino Acids, 41, 271, 10.1007/s00726-010-0689-x Kolaczkowska, 2008, Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils, Immunobiology, 213, 109, 10.1016/j.imbio.2007.07.005 Stevenson, 2012, Dry eye disease: an immune-mediated ocular surface disorder, Arch Ophthalmol, 130, 90, 10.1001/archophthalmol.2011.364 Pflugfelder, 2005, Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye, Am J Pathol, 166, 61, 10.1016/S0002-9440(10)62232-8 Smith, 2001, Tear film MMP accumulation and corneal disease, Br J Ophthalmol, 85, 147, 10.1136/bjo.85.2.147 Sambursky, 2011, MMP-9 and the perioperative management of LASIK surgery, Curr Opin Ophthalmol, 22, 294, 10.1097/ICU.0b013e32834787bb Solomon, 2001, Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease, Invest Ophthalmol Vis Sci, 42, 2283 De Paiva, 2006, Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye, Exp Eye Res, 83, 526, 10.1016/j.exer.2006.02.004 De Paiva, 2006, Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline, Invest Ophthalmol Vis Sci, 47, 2847, 10.1167/iovs.05-1281 Pflugfelder, 2004, A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance, Am J Ophthalmol, 138, 444, 10.1016/j.ajo.2004.04.052 Foulks, 2013, Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study, Cornea, 32, 44, 10.1097/ICO.0b013e318254205f Chalmers, 2010, Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses, Cont Lens Anterior Eye, 33, 55, 10.1016/j.clae.2009.12.010 Ansari, 2015, Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population, Cornea, 34, 32, 10.1097/ICO.0000000000000286 Belmonte, 1999, Measurement of corneal sensitivity to mechanical and chemical stimulation with a CO2 esthesiometer, Invest Ophthalmol Vis Sci, 40, 513 Situ, 2007, Eccentric variation of corneal sensitivity to pneumatic stimulation at different temperatures and with CO2, Exp Eye Res, 85, 400, 10.1016/j.exer.2007.06.006 Huet, 2011, EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease, Am J Pathol, 179, 1278, 10.1016/j.ajpath.2011.05.036 Galor, 2014, Neuropathic ocular pain: an important yet underevaluated feature of dry eye, Eye (Lond), 29, 301, 10.1038/eye.2014.263 Galor, 2014, Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain, Br J Ophthalmol, 99, 665, 10.1136/bjophthalmol-2014-306057 Rosenthal, 2012, The corneal pain system. Part I: the missing piece of the dry eye puzzle, Ocul Surf, 10, 2, 10.1016/j.jtos.2012.01.002 Rao, 2011, Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal, J Ocul Pharmacol Ther, 27, 603, 10.1089/jop.2011.0073